Tussiflorin Thyme
Natural health product licensed in Canada
- Other names
- Tussiflorin Thymian
- Licence holder
- Pascoe Canada
- NPN or DIN-HM
- 80092657
- Status
- Inactive licence
- Licence date
- 4 June 2019
- Revision date
- Not provided
- Form
- Sirop
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Ammoniaque Officinale, Sirop de maltitol, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | 10 millilitre | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
| Enfants | minimum: 5 years ; maximum: 11 years | 5 millilitre | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
| Enfants | minimum: 1 year ; maximum: 4 years | 5 millilitre | 2 Tous les jours |
Uses authorised in Canada
Traditionally used in Herbal Medicine as an expectorant to help relieve coughs, symptoms of bronchitis and catarrhs of upper respiratory tract.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist more than 1 week. Consult a health care practitioner if dyspnea, fever or purulent or sanguineous sputum occurs. Health risk exists among people with liver disease, alcoholics, epileptics, and people suffering from brain injury. Contains 9% (V/V) alcohol.
- Effets indésirables connus
In very rare cases, hypersensitivity reactions such as dyspnea, exanthema, urticaria or Quincke edema may occur. In very rare cases, gastric disorders such as cramps, nausea, vomiting may occur.
- Contre-indications
Contraindicated in patients who are hypersensitive to the active ingredient Thyme or other plants of the Lamiaceae family (mint family), birch, mugwort, celery or to any of the non-medicinal ingredients. Contraindicated in patients with hereditary fructose intolerance. Do not use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80092657
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.